A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2011 by Western Galilee Hospital-Nahariya.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Migal, Galilee Technology Center
Information provided by:
Western Galilee Hospital-Nahariya
ClinicalTrials.gov Identifier:
NCT01393587
First received: July 12, 2011
Last updated: July 17, 2012
Last verified: July 2011
  Purpose

Recently, a new synthetic marker was developed, based on a molecule that is composed of Amino Acids and Linoleic Acid and Neucleic Acid, which is capable of detecting even minor changes of oxidative stress.

The investigators would like to assess the usefulness of this marker during positive pressure pneumoperitoneum, during laproscopic surgery, with or without intenstinal resection (ischemia induced by intra-abdominal pressure and vascualr compromise).


Condition Intervention
Oxidative Stress
Laproscopy
Procedure: Taking blood samples

Study Type: Interventional
Official Title: A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery

Further study details as provided by Western Galilee Hospital-Nahariya:

Arms Assigned Interventions
Experimental: Experimental Procedure: Taking blood samples

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy patients undergoing elective laproscopic cholecystectomy and patients undergoing operation for tumer of large intenstine.

Exclusion Criteria:

  • Patients suffering from Cardio Pulmonory and renal diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01393587

Contacts
Contact: Amitai Bickel, Dr. +972-507887554 ext 7554 amitai@netvision.net.il
Contact: Y Mosenzon, M.A +972-49107011 ext 7022 yael.mosenzon@naharia.health.gov.il

Locations
Israel
Western Galilee Hospital Not yet recruiting
Nahariya, Israel, 22100
Principal Investigator: Amitai Bickel, Dr.         
Sponsors and Collaborators
Western Galilee Hospital-Nahariya
Migal, Galilee Technology Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01393587     History of Changes
Other Study ID Numbers: BIC-2011
Study First Received: July 12, 2011
Last Updated: July 17, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Western Galilee Hospital-Nahariya:
Oxidative Stress
Laproscopy

ClinicalTrials.gov processed this record on September 16, 2014